Comments to FDA: Internal Analgesis, Antipyretic, and Antirheumatic Products for OTC Human Use

Share page:

Comments | May 25, 2007

Docket Number:
0977N-0094L

CHPA comments on the proposed rule, which proposes new warning and other labeling requirements for internal analgesic, antipyretic, and antirheumatic OTC drug products.

Related Posts